Convenient synthesis of zwitterionic calcium(II)-carboxylate metal organic frameworks with efficient activities for the treatment of osteoporosis
Yu Hou,Cai-Zhu Luo,Deng-Hui Xie,Jing-Jing Hu,Jin-Xiang Chen,Nai-Han Huang,Hong Wang,Shu-Qing Zhang,Qun Zhang
DOI: https://doi.org/10.1016/j.ijpharm.2021.121083
IF: 6.51
2021-10-01
International Journal of Pharmaceutics
Abstract:<p>Calcium supplementation is effective in alleviating the process of osteoporosis and the occurrence of osteoporotic fractures for people with long-term calcium deficiency. Herein, five water-stable calcium carboxylate compounds, that is, mononuclear coordination compound [Ca(Cbdcp)(H<sub>2</sub>O)<sub>6</sub>]·0.5H<sub>2</sub>O (<strong>1</strong>, H<sub>3</sub>CbdcpBr = N-(4-carboxybenzyl)-(3,5-dicarboxyl)pyridinium bromide), and metal organic frameworks (MOFs) {[Ca<sub>3</sub>(Dcbdcp)<sub>2</sub>(H<sub>2</sub>O)<sub>12</sub>]·2H<sub>2</sub>O}<sub>n</sub> (<strong>2</strong>, H<sub>4</sub>DcbdcpBr = N-(3,5-dicarboxybenzyl)-(3,5-dicarboxyl)pyridinium bromide), {[Ca(Cmdcp)(H<sub>2</sub>O)<sub>4</sub>]·3H<sub>2</sub>O}<sub>n</sub> (<strong>3</strong>, H<sub>3</sub>CmdcpBr = N-carboxymethyl-(3,5-dicarboxyl)pyridinium bromide), {[Ca(Cdcbp)]·2H<sub>2</sub>O}<sub>n</sub> (<strong>4</strong>, H<sub>3</sub>CdcbpBr = 3-carboxyl-(3,5-dicarboxybenzyl)-pyridinium bromide) and {[Ca<sub>0.5</sub>(Cmcp)]·2H<sub>2</sub>O}<sub>n</sub> (<strong>5</strong>, H<sub>2</sub>CmcpBr = N-carboxymethyl-(3-carboxyl)pyridinium bromide), were synthesized from the reaction of CaCl<sub>2</sub> with five different kinds of zwitterionic carboxylate ligands in the presence of NaOH, respectively. Compounds <strong>1</strong>–<strong>5</strong> were characterized by Fourier-transform infrared (FTIR) spectroscopy, elemental analyses, single-crystal X-ray crystallography, and inductively coupled plasma mass spectrometry (ICP-MS). Compound <strong>1</strong> features a mononuclear structure and MOF <strong>2</strong> with a one-dimensional (1D) structure while MOFs <strong>3</strong> and <strong>5</strong> with 2D layer structures and MOF <strong>4</strong> showing a 3D structure. Compounds <strong>1</strong>–<strong>5</strong> exhibited good water stability and possessed considerable biocompatibility with primary mice osteoblasts. The in <em>vitro</em> ability of compounds <strong>1</strong>–<strong>5</strong> in regulating osteoblastic differentiation was studied <em>via</em> alkaline phosphatase (ALP) staining, alizarin red S (ARS) staining, and quantitative real-time polymerase chain reaction (qPCR). Among these 5 compounds, MOF <strong>4</strong> showed the overall best in <em>vitro</em> osteogenic effects. Then, we administrated MOF <strong>4</strong> intragastrically to bilaterally ovariectomized mice for 8 weeks and found that bone loss caused by ovariectomy (OVX) was significantly alleviated. Besides, MOF <strong>4</strong> administration showed no toxic effects in the main organs of the mice. Altogether, zwitterionic carboxylate ligands-based calcium compounds provide a new strategy for calcium agents development.</p>
pharmacology & pharmacy